galactitol has been researched along with Malignant Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmann, DL; Bisel, HF; Edmonson, JH; Frytak, S; Hahn, RG; O'Connell, MJ | 1 |
| Brook, J; Phillips, RW | 1 |
2 trial(s) available for galactitol and Malignant Melanoma
| Article | Year |
|---|---|
Phase II study of VP-16-213 versus dianhydrogalactitol in patients with metastatic malignant melanoma.
Topics: Drug Evaluation; Drug Therapy, Combination; Ethers, Cyclic; Etoposide; Female; Galactitol; Humans; Male; Melanoma; Podophyllotoxin; Sugar Alcohols | 1976 |
Clinical experiences with dibromodulcitol (NSC-104800) in solid tumors.
Topics: Adenocarcinoma; Adult; Aged; Alkylating Agents; Bromine; Bronchial Neoplasms; Carcinoma, Squamous Cell; Clinical Trials as Topic; Female; Galactitol; Humans; Kidney Neoplasms; Leukopenia; Male; Melanoma; Middle Aged; Nasopharyngeal Neoplasms; Neoplasms; Sugar Alcohols; Thrombocytopenia | 1971 |